Development of the NIH PROMIS® Sexual Function and Satisfaction Measures in Patients with Cancer
Article first published online: 6 FEB 2013
© 2013 International Society for Sexual Medicine
The Journal of Sexual Medicine
Special Issue: Cancer Survivorship and Sexual Health
Volume 10, Issue Supplement S1, pages 43–52, February 2013
How to Cite
Flynn, K. E., Lin, L., Cyranowski, J. M., Reeve, B. B., Reese, J. B., Jeffery, D. D., Smith, A. W., Porter, L. S., Dombeck, C. B., Bruner, D. W., Keefe, F. J. and Weinfurt, K. P. (2013), Development of the NIH PROMIS® Sexual Function and Satisfaction Measures in Patients with Cancer. Journal of Sexual Medicine, 10: 43–52. doi: 10.1111/j.1743-6109.2012.02995.x
- Issue published online: 6 FEB 2013
- Article first published online: 6 FEB 2013
- Patient-Reported Outcome Measures;
- Sexual Function;
- Quality of Life;
- Male and Female Sexual Dysfunction
Introduction. We describe the development and validation of the Patient-Reported Outcomes Measurement Information System® Sexual Function and Satisfaction (PROMIS® SexFS; National Institutes of Health) measures, version 1.0, for cancer populations.
Aim. To develop a customizable self-report measure of sexual function and satisfaction as part of the U.S. National Institutes of Health PROMIS Network.
Methods. Our multidisciplinary working group followed a comprehensive protocol for developing psychometrically robust patient-reported outcome measures including qualitative (scale development) and quantitative (psychometric evaluation) development. We performed an extensive literature review, conducted 16 focus groups with cancer patients and multiple discussions with clinicians, and evaluated candidate items in cognitive testing with patients. We administered items to 819 cancer patients. Items were calibrated using item-response theory and evaluated for reliability and validity.
Main Outcome Measures. The PROMIS SexFS measures, version 1.0, include 81 items in 11 domains: Interest in Sexual Activity, Lubrication, Vaginal Discomfort, Erectile Function, Global Satisfaction with Sex Life, Orgasm, Anal Discomfort, Therapeutic Aids, Sexual Activities, Interfering Factors, and Screener Questions.
Results. In addition to content validity (patients indicate that items cover important aspects of their experiences) and face validity (patients indicate that items measure sexual function and satisfaction), the measure shows evidence for discriminant validity (domains discriminate between groups expected to be different) and convergent validity (strong correlations between scores on PROMIS and scores on conceptually similar older measures of sexual function), as well as favorable test–retest reliability among people not expected to change (interclass correlations from two administrations of the instrument, 1 month apart).
Conclusions. The PROMIS SexFS offers researchers a reliable and valid set of tools to measure self-reported sexual function and satisfaction among diverse men and women. The measures are customizable; researchers can select the relevant domains and items comprising those domains for their study. Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, and Weinfurt KP. Development of the NIH PROMIS® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med 2013;10(suppl 1):43–52.